Metacrine, Inc.
FARNESOID X RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASE
Last updated:
Abstract:
Described herein are combination therapies with famesoid X receptor (FXR) agonists, and methods of using such pharmaceutical compositions in the treatment of conditions, diseases, or disorders associated with famesoid X receptor activity.
Status:
Application
Type:
Utility
Filling date:
17 Sep 2019
Issue date:
17 Feb 2022